MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
11.64
+0.41 (3.65%)
At close: Sep 4, 2026, 4:00 PM EDT
11.41
-0.23 (-1.98%)
After-hours: Sep 4, 2026, 7:30 PM EDT
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $59.4 million as of September 4, 2026. Its market cap has decreased by -6.69% in one year.
Market Cap
59.40M
Enterprise Value
50.59M
1-Year Change
-6.69%
Ranking
Category
Stock Price
$11.64
ChartMarket Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $59.40M, a decrease of -84.63%. That is a compound annual growth rate of -31.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 59.40M | 13.49% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alps Group | 63.23M |
| BioStem Technologies | 63.19M |
| eXoZymes | 63.02M |
| MindWalk Holdings | 62.73M |
| Apollomics | 60.05M |
| Heron Therapeutics | 59.40M |
| Xilio Therapeutics | 58.17M |
| Nutriband | 57.13M |